Sanofi to Pay $100 Million to Settle Zantac Cancer Lawsuits
- Deal to provide over $25,000 per claim over heartburn drug
- Suits accuse Sanofi, GSK of failing to warn of cancer risk
A researcher prepares to test a bottle of Zantac at a lab in 2022.
Photographer: Gabby Jones/BloombergSanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn users that its Zantac heartburn medicine could cause cancer, according to people familiar with the deal.
The settlement was announced earlier this month, but the amount was not made public at that time. The deal provides former Zantac users with an average of more than $25,000 per claim, said the people, who requested anonymity because they weren’t authorized to speak publicly.